Phase 1/Phase 2 [clinicaltrials_resource:72d8d9eabd48f679d5dffa41c4dd93f7]
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets [clinicaltrials:NCT00000102]Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 [clinicaltrials:NCT00000320]clinicaltrials:NCT00001575clinicaltrials:NCT00001849clinicaltrials:NCT00001941High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma [clinicaltrials:NCT00002465]Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer [clinicaltrials:NCT00002482]Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors [clinicaltrials:NCT00002508]High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer [clinicaltrials:NCT00002509]Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002510]clinicaltrials:NCT00002558Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin [clinicaltrials:NCT00002559]Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [clinicaltrials:NCT00002577]clinicaltrials:NCT00002602Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer [clinicaltrials:NCT00002627]Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002628]Biological Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00002637]clinicaltrials:NCT00002663Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma [clinicaltrials:NCT00002681]Monoclonal Antibody Therapy in Treating Patients With Brain Metastases [clinicaltrials:NCT00002751]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers [clinicaltrials:NCT00002752]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002761]Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002775]Biological Therapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002780]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002786]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer [clinicaltrials:NCT00002796]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002817]clinicaltrials:NCT00002831clinicaltrials:NCT00002832clinicaltrials:NCT00002837clinicaltrials:NCT00002838Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer [clinicaltrials:NCT00002873]Paclitaxel in Treating Patients With Early-Stage Bladder Cancer [clinicaltrials:NCT00002917]Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00002925]Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002950]clinicaltrials:NCT00002952clinicaltrials:NCT00002984Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer [clinicaltrials:NCT00003001]Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [clinicaltrials:NCT00003037]
phase [clinicaltrials_vocabulary:phase]
Phase 1/Phase 2 [clinicaltrials_resource:72d8d9eabd48f679d5dffa41c4dd93f7]
Bio2RDF identifier
72d8d9eabd48f679d5dffa41c4dd93f7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:72d8d9eabd48f679d5dffa41c4dd93f7
identifier
clinicaltrials_resource:72d8d9eabd48f679d5dffa41c4dd93f7
title
Phase 1/Phase 2
@en
type
label
Phase 1/Phase 2 [clinicaltrials_resource:72d8d9eabd48f679d5dffa41c4dd93f7]
@en